World News – UK – Medicines Patent Pool expands agreement for access to critical HIV drugs


. .

To expand access to a major AIDS drug, ViiV Healthcare and the drug patent pool have reached an agreement that will allow generic drug makers to get Tivicay treatment for four higher-middle-income countries by 50% to 70% versus to offer the existing prices.

The deal will allow lower-cost versions to reach Azerbaijan, Belarus, Kazakhstan and Malaysia after the countries were not excluded from a 2014 licensing agreement that covers dozens of low and middle income countries. Although classified as higher-middle-income countries by the World Bank, all four governments argued that current pricing is preventing treatment for many patients.

STAT is STAT’s premium subscription service for in-depth reporting and analysis in the biotechnology, pharma, politics and life sciences sectors.
Our award-winning team covers the news on Wall Street, Washington policy developments, early scientific breakthroughs and clinical trial results, and health care disruptions in Silicon Valley and beyond.

Dolutegravir, HIV, HIV / AIDS, ViiV Healthcare Limited, GlaxoSmithKline

World News – UK – The Patent Pool for Medicines expands the agreement for access to critical HIV medicines
. . Related title :
The Medicines Patent Pool extends the agreement on access to essential HIV drugs to several countries with higher middle income
Malaysia Gets Cheaper Access to Key HIV Drug
ViiV Healthcare and the Medicines Patent Pool are expanding access to dolutegravir-based therapies for the people they live with . . .


Donnez votre avis et abonnez-vous pour plus d’infos

Vidéo du jour: